Debbie Ledezma

Title(s)Postdoctoral Scholar, Nanoengineering
SchoolVc-academic Affairs
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent. Nanomedicine (Lond). 2022 12; 17(29):2159-2171. Balakrishnan PB, Holmberg CS, Ledezma DK, Bosque A, Fernandes R. PMID: 36734362; PMCID: PMC10061244.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Interstitial Photothermal Therapy Generates Durable Treatment Responses in Neuroblastoma. Adv Healthc Mater. 2022 10; 11(20):e2201084. Ledezma DK, Balakrishnan PB, Shukla A, Medina JA, Chen J, Oakley E, Bollard CM, Shafirstein G, Miscuglio M, Fernandes R. PMID: 35943173; PMCID: PMC9588730.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    3. Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma. Nanomaterials (Basel). 2022 Aug 01; 12(15). Bonan NF, Ledezma DK, Tovar MA, Balakrishnan PB, Fernandes R. PMID: 35957076; PMCID: PMC9370342.
      View in: PubMed   Mentions: 3  
    4. The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma Cells. Cancers (Basel). 2022 Mar 11; 14(6). Sekhri P, Ledezma DK, Shukla A, Sweeney EE, Fernandes R. PMID: 35326601; PMCID: PMC8945975.
      View in: PubMed   Mentions: 5  
    5. CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma. Nano Res. 2022 Mar; 15(3):2300-2314. Balakrishnan PB, Ledezma DK, Cano-Mejia J, Andricovich J, Palmer E, Patel VA, Latham PS, Yvon ES, Villagra A, Fernandes R, Sweeney EE. PMID: 36089987; PMCID: PMC9455608.
      View in: PubMed   Mentions: 5  
    6. CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma. Transl Oncol. 2020 Oct; 13(10):100823. Cano-Mejia J, Shukla A, Ledezma DK, Palmer E, Villagra A, Fernandes R. PMID: 32652470; PMCID: PMC7348061.
      View in: PubMed   Mentions: 16  
    7. Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma. Nanomaterials (Basel). 2020 Jan 17; 10(1). Ledezma DK, Balakrishnan PB, Cano-Mejia J, Sweeney EE, Hadley M, Bollard CM, Villagra A, Fernandes R. PMID: 31963449; PMCID: PMC7022377.
      View in: PubMed   Mentions: 11  
    Debbie's Networks
    Concepts (15)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department